Karin Veerman

519 total citations
5 papers, 94 citations indexed

About

Karin Veerman is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Karin Veerman has authored 5 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Neurology and 2 papers in Epidemiology. Recurrent topics in Karin Veerman's work include COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers) and Total Knee Arthroplasty Outcomes (1 paper). Karin Veerman is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers) and Total Knee Arthroplasty Outcomes (1 paper). Karin Veerman collaborates with scholars based in Netherlands, Australia and Germany. Karin Veerman's co-authors include Katrijn Smulders, Jon H. M. Goosen, Denise Telgt, Marc J. T. Blaauw, Josephine van de Maat, Marjan van Apeldoorn, Jacobien J. Hoogerwerf, Nico Janssen, Quirijn de Mast and Reinout van Crevel and has published in prestigious journals such as PLoS ONE, British Journal of Clinical Pharmacology and The Bone & Joint Journal.

In The Last Decade

Karin Veerman

4 papers receiving 91 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Veerman Netherlands 4 45 34 27 24 10 5 94
Woo Chiao Tay Singapore 3 86 1.9× 26 0.8× 24 0.9× 23 1.0× 16 1.6× 6 119
Karthikeyan Arcot United States 5 28 0.6× 28 0.8× 69 2.6× 8 0.3× 20 2.0× 11 90
Fen Ai China 4 34 0.8× 22 0.6× 14 0.5× 26 1.1× 15 1.5× 4 72
Robin Dharia United States 5 45 1.0× 7 0.2× 39 1.4× 13 0.5× 25 2.5× 15 96
Jonathan Tschopp Switzerland 6 117 2.6× 23 0.7× 39 1.4× 34 1.4× 34 3.4× 9 153
Carlos Jiménez Martín Spain 4 79 1.8× 24 0.7× 50 1.9× 35 1.5× 6 0.6× 7 110
Valentin Pointurier France 4 71 1.6× 7 0.2× 34 1.3× 33 1.4× 7 0.7× 6 95
Jos A. H. van Oers Netherlands 6 32 0.7× 11 0.3× 20 0.7× 9 0.4× 34 3.4× 12 77
Hibba Kurdi United Kingdom 5 29 0.6× 6 0.2× 8 0.3× 18 0.8× 6 0.6× 17 72
Brooke Leitgeb United States 2 59 1.3× 9 0.3× 26 1.0× 5 0.2× 11 1.1× 3 68

Countries citing papers authored by Karin Veerman

Since Specialization
Citations

This map shows the geographic impact of Karin Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Veerman more than expected).

Fields of papers citing papers by Karin Veerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Veerman. The network helps show where Karin Veerman may publish in the future.

Co-authorship network of co-authors of Karin Veerman

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Veerman. A scholar is included among the top collaborators of Karin Veerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Veerman. Karin Veerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Debisarun, Priya A., Rutger J. Röring, Özlem Bulut, et al.. (2025). Long‐term effects of influenza and Bacille Calmette–Guérin vaccination on systemic inflammation. Clinical & Translational Immunology. 14(9). e70047–e70047.
2.
Veerman, Karin, et al.. (2022). Debridement, antibiotics, and implant retention after revision arthroplasty. The Bone & Joint Journal. 104-B(4). 464–471. 33 indexed citations
3.
Gelder, Marleen M. H. J. van, Marcel M.C. Hovens, Anton S. M. Dofferhoff, et al.. (2021). Prior use of therapeutic anticoagulation does not protect against COVID‐19 related clinical outcomes in hospitalized patients: A propensity score‐matched cohort study. British Journal of Clinical Pharmacology. 87(12). 4839–4847. 19 indexed citations
4.
Maat, Josephine van de, Karin Veerman, Jaap ten Oever, et al.. (2021). Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study. PLoS ONE. 16(3). e0248713–e0248713. 27 indexed citations
5.
Ramjith, Jordache, Nico Janssen, Jacobien J. Hoogerwerf, et al.. (2021). Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis. PLoS ONE. 16(3). e0249231–e0249231. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026